%0 Journal Article
%T Mutations, substitutions, and selection: Linking mutagenic processes to cancer using evolutionary theory.
%A Cannataro VL
%A Glasmacher KA
%A Hampson CE
%J Biochim Biophys Acta Mol Basis Dis
%V 1870
%N 7
%D 2024 10 30
%M 38823460
%F 6.633
%R 10.1016/j.bbadis.2024.167268
%X Cancers are the product of evolutionary events, where molecular variation occurs and accumulates in tissues and tumors. Sequencing of this molecular variation informs not only which variants are driving tumorigenesis, but also the mechanisms behind what is fueling mutagenesis. Both of these details are crucial for preventing premature deaths due to cancer, whether it is by targeting the variants driving the cancer phenotype or by measures to prevent exogenous mutations from contributing to somatic evolution. Here, we review tools to determine both molecular signatures and cancer drivers, and avenues by which these metrics may be linked.